Skip to content

New optical techniques in interstitial lung disease

New optical techniques in interstitial lung disease - New optical techniques in ILD

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON55811
Enrollment
20
Registered
2019-11-18
Start date
2019-11-27
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diffuse Parenchymal Lung disease Interstitial lung disease

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Interstitial lung disease patients with an indication for lung tissue sampling

Exclusion criteria

Exclusion criteria: * Inability and willingness to provide informed consent * Inability to comply with study protocol * Use of clopidogrel, or other new anti-platelet therapy, or anticoagulant drugs that cannot be stopped temporarily * Thrombocytopenia 1.3 * Pregnancy

Design outcomes

Primary

MeasureTime frame
-To describe visual qualitative characteristics of CLE, OCT and HHGM images of the alveolar compartment and the airway wall in ILD -To obtain quantitative measurements of ILD by analysis of the CLE, OCT and HHGM imaging of the alveolar compartment (size of the alveoli (um), thickness of the alveolar septum) -To compare the CLE, OCT and HHGM images with pathology results -To identify specific structures and cells (i.e. collagen fibres, elastin, inflammatory cells) on HHGM images of lung tissue -To identify specific structures and cells (i.e. collagen fibres, elastin, inflammatory cells) on HHGM images in ILD

Secondary

MeasureTime frame
-To create an image atlas with pOCT, pCLE and HHGM images of the airway wall and alveolar compartment in ILD -Assessing procedure-related adverse events of pCLE and pOCT -Assessing technical feasibility of pCLE, pOCT and HHGM -To assess the timeframe that is necessary for adequate HHGM images of lung tissue in ILD

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)